Better Quantum Computing Stock: Rigetti Computing vs. D-Wave Quantum
Quantum computing could make it easier to process massive amounts of information in the near future. Unlike traditional computers, which still store data in binary bits of zeros and ones, quantum computers can store them simultaneously in qubits.
That approach enables quantum computers to process data much faster than binary computers, but the ones in operation now are also larger, more expensive, and consume more power while making more mistakes than binary computers. Those shortcomings are preventing quantum computers from being used for mainstream applications, so they're still mainly used for niche research purposes.
But over the next few years, companies are working to make quantum computers smaller, less expensive, and more accurate as the technology improves. According to Fortune Business Insights, the quantum computing market could still expand at a compound annual growth rate (CAGR) of 34.8% from 2024 to 2032 -- so this industry's early movers might be future multi-baggers.
Two of those early movers, Rigetti Computing (NASDAQ: RGTI) and D-Wave Quantum (NYSE: QBTS), saw their stocks surge nearly 470% and 390% over the past 12 months, respectively, as the market attracted a stampede of bulls. But should investors chase either of those high-flying stocks right now?
Rigetti designs and manufactures its own quantum processing units (QPUs), builds full quantum computing systems, and hosts a developer-oriented cloud infrastructure platform for quantum computing applications. That vertically integrated approach makes it a "full stack" play on the quantum computing market. It serves big customers like the Superconducting Quantum Materials and Systems Center (SQMS), Air Force Research Lab (AFRL), and Horizon Quantum Computing in Singapore.
It launched the Novera QPU, a 9-qubit commercial version of its quantum computer that costs about $900,000, in late 2024. It also recently deployed its first 84-qubit Ankaa-3 quantum computing system, which can detect over 99% of its errors (known as its "median gate fidelity" ratio), to support its cloud-based platform.
This year, it plans to launch a new modular quantum computing system that links together four 9-qubit chips to create a 36-qubit system with a median gate fidelity of 99.5%. It also aims to deploy a non-modular system with more than 100 qubits by the end of 2026, and an even more powerful 336-qubit system within the next few years.
D-Wave Quantum carved out its niche with its quantum annealing tools, which help organizations optimize their workflow, schedules, supply chains, and logistics networks. It achieves that like an automated efficiency expert that maps out large amounts of data to find the solutions that require the least computing power.
It sells both its own hardware and its own cloud-based services through its Leap quantum platform, which can be integrated into larger cloud infrastructure platforms like Amazon Web Services (AWS). It also calibrated its new 4,400-qubit Advantage2 processor -- which solves complex 3D lattice problems 25,000 times faster than its current Advantage processor -- last November. That upgrade could help it optimize its clients' operations much more efficiently.
It's already signed on big clients like Deloitte, Mastercard, Lockheed Martin, and Accenture, and it could continue to attract more customers with its focus on using quantum computing for more practical applications.
Rigetti and D-Wave both have promising strategies for the quantum computing market, but a lot of that future growth has already been priced into their high-flying shares. Rigetti and D-Wave have enterprise values of $2.83 billion and $3.09 billion, respectively, but this is how much revenue they're expected to generate through 2027.
Metric
2025
2026
2027
Rigetti revenue (growth rate)
$14.0 million (30%)
$33.6 million (140%)
$49.7 million (48%)
D-Wave revenue (growth rate)
$22.4 million (1%)
$34.4 million (54%)
$72.1 million (109%)
Data source: Marketscreener. Note: Dollar figures are estimates and growth rates are year over year.
Therefore, Rigetti already trades at 57 times its projected sales for 2027, while D-Wave trades at 43 times that estimate. Investors should also take those estimates with a grain of salt, since the quantum computing market remains in its infancy.
Furthermore, both companies are also expected to stay unprofitable for at least the next three years, and they've been severely diluting their existing investors with high stock-based compensation expenses and secondary offerings to raise fresh cash. Over the past 12 months, Rigetti and D-Wave increased their outstanding shares by 73% and 80%, respectively, and that dilution should continue for the foreseeable future.
During that past year, Rigetti's insiders sold nearly 4 times as many shares as they bought, but D-Wave's insiders bought 8% more shares than they sold. That warmer insider sentiment suggests D-Wave might have a bit more upside potential.
I personally wouldn't buy either of these quantum computing stocks at these sky-high valuations. But if I had to choose one over the other, I'd invest in D-Wave Quantum because its growth is accelerating, its stock is slightly cheaper than Rigetti's, its insiders are still net buyers, and its technology seems better suited for mainstream customers than research institutions.
Before you buy stock in Rigetti Computing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $721,394!*
Now, it's worth noting Stock Advisor's total average return is 839% — a market-crushing outperformance compared to 164% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of March 18, 2025
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Leo Sun has positions in Amazon. The Motley Fool has positions in and recommends Accenture Plc, Amazon, and Mastercard. The Motley Fool recommends Lockheed Martin. The Motley Fool has a disclosure policy.
Better Quantum Computing Stock: Rigetti Computing vs. D-Wave Quantum was originally published by The Motley Fool
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit
Johnson & Johnson (NYSE:JNJ) is one of the best Dow stocks to invest in. Recently, a federal judge ruled that a Johnson & Johnson subsidiary must pay $442 million in damages after a jury concluded last month that the company had broken antitrust laws by withholding support from hospitals that used reprocessed catheters. U.S. District Judge James Selna ordered the company to pay three times the $147 million in damages awarded by the jury, as permitted under antitrust regulations. This sum does not include legal fees or other related costs. Daniel Vukelich, CEO of the Association of Medical Device Reprocessors, described the decision as 'a seismic result.' In response, a Johnson & Johnson (NYSE:JNJ) spokesperson said the company intends to appeal the verdict but will comply with the court's decision and any required relief for now. The spokesperson added, 'We strongly disagree with the jury's verdict and believe it will not withstand appellate review.' Innovative Health sued Johnson & Johnson (NYSE:JNJ)'s Biosense Webster in 2019, claiming the company used its market power to block hospitals from using reprocessed heart-mapping catheters by tying support for its Carto 3 system to purchases of its own products. A jury found Johnson & Johnson (NYSE:JNJ) violated antitrust laws by withholding support for the reprocessed devices. AMDR's CEO said the ruling signals that anti-competitive tactics against reprocessing won't be tolerated. The case was heard in the U.S. District Court for the Central District of California. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.
Yahoo
33 minutes ago
- Yahoo
Fortrea Names Anshul Thakral Chief Executive Officer
Thakral succeeds Interim CEO, Peter M. Neupert, who will remain chairman of the board DURHAM, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the 'Company'), a leading global contract research organization (CRO), today announced that Fortrea's Board of Directors (the 'Board') named Anshul Thakral as Fortrea's CEO, effective August 4, 2025. He was also appointed to serve as a director on the Company's Board, effective as of that date. Thakral succeeds Interim CEO, Peter M. Neupert, who will remain as chairman of the board. Thakral brings more than 20 years of experience in life sciences as an executive and commercial leader, advisor and entrepreneur. He will focus on executing the Company's transformation plan and sharpening Fortrea's focus on profitable growth. Further, he will oversee additional value creation efforts for customers, employees and shareholders. 'Anshul is an exceptional leader with extensive life sciences experience, deep familiarity with the CRO industry, a commitment to innovation and a proven record of building companies and growing revenue,' said Neupert. 'His strong business development capabilities, commercial insights and relentless focus on customer engagement make him ideally suited to lead Fortrea. Further, he also shares the Company's commitment to modernizing the clinical trials process and combining the best talent, science and technology to effectively and efficiently respond to changing customer and patient needs. We are delighted to welcome Anshul to Fortrea as we seek to capitalize on the significant growth opportunities we see ahead and meet our customers' needs.' 'Since its founding, the Fortrea team has earned a strong reputation for leading with science and creating a differentiated customer experience,' said Thakral. 'I share the team's passion for customers and the patients they serve, and I'm honored to take the reins at this pivotal moment. It is an exciting opportunity to lead the organization as it continues to deliver flexible and agile drug development solutions that accelerate the delivery of life-changing treatments to patients. I'm confident this company can execute on its patient and customer-focused mission while delivering profitable growth, which ultimately delivers value for shareholders.' About Anshul Thakral Thakral joins Fortrea from Launch Therapeutics, a company he co-founded at which he served as CEO. Previously, he held several executive leadership roles at PPD, a leading CRO, including chief commercial officer and executive vice president of Peri- and Post-Approval Services. He led PPD Biotech, which contributed to PPD's growth. Prior to PPD, Thakral ran the global life sciences business unit at Gerson Lehrman Group and served as an Associate Principal at McKinsey & Company in the healthcare practice. He currently serves on the board of directors of TriNetX, Saama Technologies and Orsini Specialty Pharmacy. He earned his B.S. and M.S.E. in Biomedical Engineering from Johns Hopkins University and his MBA from the Wharton School at the University of Pennsylvania. About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at and follow us on LinkedIn and X (formerly Twitter). Cautionary Statement Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, the Company's growth opportunities. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as 'guidance,' 'expect,' 'assume,' 'anticipate,' 'intend,' 'plan,' 'forecast,' 'believe,' 'seek,' 'see,' 'will,' 'would,' 'target,' similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from the Company's expectations due to a number of factors, including, but not limited to, the following: the Company's ability to successfully implement its business strategies and execute its long-term value creation strategy; risks and expenses associated with the Company's international operations, tariff policies, trade sanctions and other trade restrictions and currency fluctuations; the Company's customer or therapeutic area concentrations; any further deterioration in the macroeconomic environment or further changes in government regulations and funding, which could lead to defaults or cancellations by the Company's customers; the risk that the Company's backlog and net new business may not be indicative of the Company's future revenues and that the Company might not realize all of the anticipated future revenue reflected in the Company's backlog; the Company's ability to generate sufficient net new business awards, or the possibility that net new business awards are delayed, terminated, reduced in scope, or fail to go to contract; if the Company underprices its contracts, overruns its cost estimates, or fails to receive approval for, or experiences delays in documentation of change orders; and other factors described from time to time in documents that the Company files with the SEC. For a further discussion of the risks relating to the Company's business, see the 'Risk Factors' Section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission (the "SEC"), as such factors may be amended or updated from time to time in the Company's subsequent periodic and other filings with the SEC, which are accessible on the SEC's website at These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in the Company's filings with the SEC. All forward-looking statements are made only as of the date of this release and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. Contacts: Hima Inguva (Investors) – 877-495-0816, Sue Zaranek (Media) – 919-943-5422, media@ Kate Dillon (Media) – 646-818-9115, kdillon@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
E-2 Hawkeye Replaces USAF E-3 Sentry, E-7 Cancelled In New Budget
A seismic shift has occurred in the Trump administration's new defense spending plan that is just emerging when it comes to the USAF's airborne early warning and control (AEW&C) predicament. The service's E-3 Sentry Airborne Warning and Control System (AWACS) aircraft are dwindling in number and rapidly aging into unsupportability. The proven and in-production E-7 Wedgetail, based on the Boeing 737 and serving with multiple allies, was supposed to bridge the gap between the E-3's retirement and pushing the sending part of the mission to space-based distributed satellite constellations. You can read all about this here. Now, if the administration gets its wish, that won't happen. The E-7 will be cancelled and the E-2D Hawkeye, currently flown by the U.S. Navy, will step in to fill the gap. This major turn of events came to light today as Secretary of Defense Pete Hegseth, Chairman of the Joint Chiefs of Staff U.S. Air Force Gen. John Caine, and Bryn Woollacott MacDonnell testified before the Senate Appropriations Committee. MacDonnell is Special Assistant to the Secretary of Defense and is currently performing the duties of the Under Secretary of Defense (Comptroller) and the Pentagon's Chief Financial Officer. In 2023, the USAF announced its intention to purchase E-7s, potentially as many as 26 of them, as replacements for a portion of the E-3 fleet. At the hearing today, the question of the current future of the USAF AEW&C force came from Sen. Lisa Murkowski late in the hearing. Murkowski is a Republican from Alaska, where fighters, tankers, and E-3 Sentry jets launch regularly to intercept foreign planes, primarily Russian fighters, bombers, and surveillance aircraft, over the vast arctic wilderness. Chinese H-6 missile carrier aircraft also appeared off Alaska last year for the first time, as part of a joint mission with Russia. Chinese air and naval presence in the region is only expected to grow in the future. China and Russia conduct joint air strategic patrol over Bering Sea on July 25. This marks the eighth air strategic patrol organized by the two militaries since from China PLA Air Force Weibo accounthttps:// — Ryan Chan 陳家翹 (@ryankakiuchan) July 25, 2024 With this in mind, just how big of an issue the age of the E-3 fleet has become was central to Murkowski's question. 'I have been concerned. We have E-3 capability up north, of course, but we were all counting on the E-7 Wedgetail coming our way. We're kind of limping along up north right now, which is unfortunate. And the budget proposes terminating the program. Again, the E-3 fleet [is] barely operational now, and I understand the intent to shift towards the space-based – you call it the 'air moving target indicators' – but my concern is that you've got a situation where you're not going to be able to use more duct tape to hold things together until you put this system in place. And, so, how we maintain that level of operational readiness and coverage, I'm not sure how you make it.' 'You know, the E-3 and the E-3 community have been really important to us for a long, long time, and I'll defer to the Comptroller, but I you know the Department has a bridging strategy through investing in some additional airborne platforms in order to gap fill while the space-based capabilities come online,' Kane replied in response to the senator's question. This is where the E-2D comes in. MacDonnell then added, 'Ma'am, we do have in the budget $150 million in FY26 [Fiscal Year 2026] for a joint expeditionary E-2D unit with five dedicated E-2Ds, and the budget also funds for additional E-2Ds to fill the near-term gap at $1.4 billion.' Currently, the only branch of the U.S. military that operates the E-2D is the U.S. Navy. The Alaskan senator then inquired, 'Can you tell me, will that have implications for what we're seeing up north in Alaska?' 'The answer is yes. I would. I would file this entire discussion under difficult choices that we have to make. But you know, the E-7, in particular, is sort of late, more expensive and 'gold plated,' and so filling the gap, and then shifting to space-based ISR [intelligence, surveillance, and reconnaissance] is a portion of how we think we can do it best, considering all the challenges,' Hegseth responded. At a separate hearing before the House Appropriations Committee yesterday, Hegsteth had also described the Wedgetail as an example of a capability that is 'not survivable in the modern battlefield' and mentioned broad plans 'to fund existing platforms that are there more robustly and make sure they're modernized.' An annual assessment of high-profile U.S. military procurement programs from the Government Accountability Office (GAO), a Congressional watchdog, which was released today, offers additional insight into issues with the USAF's effort to acquire E-7s. The original plan was to acquire a pair of production representative prototype (or RP) aircraft ahead of production of examples in a finalized configuration, starting this year. The service had then expected to reach initial operational capability with the Wedgetail in 2027. 'Air Force officials said that they now plan to begin production by the second quarter of fiscal year 2026 before completing the E-7A RP MTA [Middle Tier Acquisition] rapid prototyping effort by initiating a separate, concurrent program on the major capability acquisition pathway,' according to GAO. 'They said that it was necessary to begin production concurrently with the E-7A RP rapid prototyping effort to offset the lead time associated with the build and subsequent modification of the aircraft.' 'The program definitized its contract with Boeing since our last assessment. After the contract was definitized, Boeing delayed the first flight test by 9 months to May 2027,' the report adds. 'According to Air Force officials, the delay was due to a late-breaking, required critical security architecture change that affected the procurement of parts, qualification testing, and modification of the airframe.' 'The program stated that the Air Force definitized the MTA rapid prototyping effort contract in August 2024 to deliver two operationally capable E-7A prototype aircraft in fiscal year 2028,' GAO's new assessment further notes. 'The program added that the total acquisition cost increase of 33 percent resulted from updated methodologies to include additional scope related to non-recurring engineering, with the primary drivers being software and air vehicle subsystems.' Last year, the Air Force had been very open about the difficulties it was having finalizing a contract with Boeing for the RP jets. The two parties ended up agreeing on a deal valued at nearly $2.6 billion. A contracting notice the service put out earlier this year also pointed to significant expected differences between the RP aircraft and the full production examples, including the possibility of a new radar. Existing versions of the E-7 in service elsewhere globally today are equipped with Northrop Grumman's Multi-Role Electronically Scanned Array (MESA) radar. The USAF's move to drop the E-7 and leverage the E-2D, which is already in the Pentagon's stable, prompts many questions. For instance, just how many of these aircraft will the USAF end up with? As of 2024, the USAF's E-3 fleet stood at 16 aircraft. Above all else, there are major capability trades here. The Hawkeye is a much smaller aircraft than both the Sentry and the Wedgetail. It is extremely capable, but it is also optimized to exist within the confines of carrier operations. The crew size is just five individuals. This limits the amount of shear manpower to perform highly complex operations and other tasks beyond traditional AEW&C. The E-2 also has less range and is far slower than both the E-3 and E-7. This means longer transit times, and the aircraft doesn't fit in as seamlessly with the jet-centric operations for the counter-air mission the service currently enjoys. The E-2D's AN/APY-9 radar from Lockheed Martin is hugely capable, but many of its other advanced data fusion and relay systems are unique to the Navy. These systems would either be stripped or just left unused for USAF-focused operations. It's also possible that other systems will replace them, but this will cost money and take time to integrate and field. Hawkeyes, being turboprop aircraft, also operate at lower altitudes, giving their radar, radio systems, and electronic surveillance suites reduced line-of-sight, limiting their range and fidelity at distance for some targets and surveillance application, in some cases. Then there is the aerial refueling issue. The E-2D has gained this ability relatively recently, which expands its endurance. Typical missions can now last over seven hours. However, the aircraft uses the Navy-preferred probe-and-drogue refueling method, not the boom and receptacle one favored by the USAF. The USAF's KC-46 tankers do have a hose and drogue system and some of the service's KC-135Rs have podded hose and drogue systems. Otherwise, they require a basket attachment to their boom, often called the 'Iron Maiden' or 'Wrecking Ball,' due to its rigid metal frame and potential to smack into and damage airframes. This system makes the KC-135R useless for refueling receptacle-equipped aircraft when it is fitted. The E-2D also refuels lower-and-slower than jet aircraft. All these issues are not 'show-stoppers,' but they are ones that will impact operational planning and flexibility. The E-2D, being already a highly upgraded and a much smaller airframe, also lacks the same capacity for future expansion compared to the E-7. This could include adding more personnel for various non-traditional functions, including using its advanced radar to scan the surface more extensively or for unique battle management needs, such as controlling future drone swarms, or even for more extensive passive intelligence collection and exploitation and data fusion operations. High-bandwidth datalinks can possibly make up for some of the manpower differentials, allowing folks on the ground to execute critical functions in near real time as part of a distributed crew arrangement, but there are downfalls to this concept, as well. On the other hand, having commonality with the Navy's AEW&C aircraft should help reduce costs for both services and accelerate the type's entry into USAF service. It could also benefit the future evolution of the E-2D as more money will be flowing into the program. It's also a very capable and well-proven platform, lowering risk. Above all else, joint service E-2Ds could be absolutely critical to the USAF's Agile Combat Employment (ACE) combat doctrine that will see its forces distributed to remote forward locales and constantly in motion. The E-2D's turboprop performance, robust landing gear, and arrested landing capabilities mean it can be pushed far forward to very austere operating locations with limited runway length. And it can do this without sacrificing the quality of the data it collects or the efficacy of its use as a battle manager. This is something a 707 or 737 platform simply cannot match and could prove decisive in a major peer-state contingency. TWZ highlighted these exact benefits after U.S. Central Command (CENTCOM) released a video last year showing a Navy Hawkeye refueling from a USAF HC-130J Combat King II combat search and rescue aircraft, which can act as a probe-and-drogue tanker, primarily for helicopters and Osprey tiltrotors. A @USNavy E-2D refuels inflight from an @usairforce HC-130 over the U.S. Central Command area of responsibility. — U.S. Central Command (@CENTCOM) August 6, 2024 While the USAF's move away from the E-7 is certainly surprising, and it will result in shortfalls in some areas, it also unlocks new capabilities, some of which are arguably more applicable to tomorrow's wars. It also buys down additional risk, which is looming very large as it isn't clear at this time, at least publicly, how far along the Pentagon's persistent space-based aircraft sensing constellation development actually is. All of this still has to make it through congressional approval, which could be a challenge considering the special interests involved. But as it sits now, the flying service is pivoting big once again when it comes to its increasingly dire AEW&C needs. Contact the author: Tyler@